↓ Skip to main content

Pyrotinib combined with thalidomide in advanced non-small-cell lung cancer patients harboring HER2 exon 20 insertions (PRIDE): protocol of an open-label, single-arm phase II trial

Overview of attention for article published in BMC Cancer, September 2021
Altmetric Badge

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
33 Mendeley